vitro primary human coronary artery smooth muscle cells hcsmcs Search Results


90
ScienCell human colonic smooth muscle cells (hcsmc
Human Colonic Smooth Muscle Cells (Hcsmc, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/human+colonic+smooth+muscle+cells/10__1074_slash_jbc__m115__678979-130-0-16
Average 90 stars, based on 1 article reviews
human colonic smooth muscle cells (hcsmc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ScienCell human cerebral microvascular smcs (hcsmcs
Human Cerebral Microvascular Smcs (Hcsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/human+cerebral+microvascular+smcs++hcsmcs/pmc05738666-226-13-23
Average 90 stars, based on 1 article reviews
human cerebral microvascular smcs (hcsmcs - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CellSystems Biotechnologie Vertrieb GmbH human coronary smooth muscle cells (csmc)
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Human Coronary Smooth Muscle Cells (Csmc), supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/human+coronary+artery+smooth+muscle+cells/pmc02676633-25-0-8
Average 90 stars, based on 1 article reviews
human coronary smooth muscle cells (csmc) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
Cell Applications Inc primary hcsmcs
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Primary Hcsmcs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/Human+Carotid+Artery+Smooth+Muscle+Cells%3A+HCtASMC/pm33959644-101-0-5
Average 95 stars, based on 1 article reviews
primary hcsmcs - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
ScienCell hcsmcs
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Hcsmcs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/hcsmcs/pmc05226563-158-0-2
Average 90 stars, based on 1 article reviews
hcsmcs - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ScienCell smc basal medium
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Smc Basal Medium, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/smc+culture+medium/pmc10807270-24-13-17
Average 90 stars, based on 1 article reviews
smc basal medium - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
AUTODOCK GmbH autodock vina software
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Autodock Vina Software, supplied by AUTODOCK GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/autodock+vina/pmc07232545-235-0-4
Average 90 stars, based on 1 article reviews
autodock vina software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CellSystems Biotechnologie Vertrieb GmbH smooth muscle cell growth medium
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Smooth Muscle Cell Growth Medium, supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/smooth+muscle+cell+growth+medium/us07229760-1040-18-23
Average 90 stars, based on 1 article reviews
smooth muscle cell growth medium - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Bachem oxidised low-density lipids
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Oxidised Low Density Lipids, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/oxidized+ldl/10__1079_slash_bjn20041113-150-7-25
Average 90 stars, based on 1 article reviews
oxidised low-density lipids - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ScienCell human cardiac fibroblasts hcf, adult ventrical
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Human Cardiac Fibroblasts Hcf, Adult Ventrical, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/human+cardiac+fibroblasts+adult+ventricular/10__5897_slash_ajb11__511-71-7-19
Average 90 stars, based on 1 article reviews
human cardiac fibroblasts hcf, adult ventrical - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CellSystems Biotechnologie Vertrieb GmbH fetal calf serum
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Fetal Calf Serum, supplied by CellSystems Biotechnologie Vertrieb GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/fetal+calf+serum/us07229760-1040-26-29
Average 90 stars, based on 1 article reviews
fetal calf serum - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

99
ATCC porphyromonas gingivalis shah and collins
Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells <t>(CSMC)</t> (A), <t>CSMC</t> treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.
Porphyromonas Gingivalis Shah And Collins, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitro+primary+human+coronary+artery+smooth+muscle+cells+hcsmcs/Porphyromonas+gingivalis+Shah+and+Collins/custom%4033277%4010%2E5897%2Fajb11%2E511
Average 99 stars, based on 1 article reviews
porphyromonas gingivalis shah and collins - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells (CSMC) (A), CSMC treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.

Journal: International Journal of Nanomedicine

Article Title: Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles

doi:

Figure Lengend Snippet: Cell cycle phase distribution. Cell cycle phase distribution was evaluated for non-treated human coronary smooth muscle cells (CSMC) (A), CSMC treated by a commonly used transfection reagent (B), and poly(DL-lactide-co-glycolide) (PLGA) microparticles (C). Cell cycle phase distribution was performed by a DNA double staining DNA procedure which enables determination of the amount of total DNA/per cell (reported on the abscissa as FL3-A) and the amount of newly synthesized DNA (reported on the ordinates as FL2-H). Based on these measurement it is possible to calculate the amount of cells in the different phases of the cell cycle as reported in each panel. G1/G0 = cells in the initial phase of cell cycle; S = cells synthesizing new DNA; G2-M = cells in the process of division (cytokinesis). No substantial differences were detected among the different treatments.

Article Snippet: Human coronary smooth muscle cells (CSMC), purchased from CellSystems Biotechnologies GmbH, had no more than 9 doublings when used in the experiments.

Techniques: Transfection, Double Staining, Synthesized

Summarized cell cycle phase distribution data. Cell cycle phase distribution was evaluated for non-treated cells human coronary smooth muscle cells (CSMC), CSMC treated by a commonly used transfection reagent (liposome), and poly(DL-lactide-co-glycolide) (PLGA) microparticles. Data are reported as means ± SD (n=3). No statistically significant differences were noted among the different treatments.

Journal: International Journal of Nanomedicine

Article Title: Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles

doi:

Figure Lengend Snippet: Summarized cell cycle phase distribution data. Cell cycle phase distribution was evaluated for non-treated cells human coronary smooth muscle cells (CSMC), CSMC treated by a commonly used transfection reagent (liposome), and poly(DL-lactide-co-glycolide) (PLGA) microparticles. Data are reported as means ± SD (n=3). No statistically significant differences were noted among the different treatments.

Article Snippet: Human coronary smooth muscle cells (CSMC), purchased from CellSystems Biotechnologies GmbH, had no more than 9 doublings when used in the experiments.

Techniques: Transfection